U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C23H27N3O.C14H10O4
Molecular Weight 603.7068
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PRENOXDIAZINE HIBENZATE

SMILES

OC(=O)C1=CC=CC=C1C(=O)C2=CC=C(O)C=C2.C(CC3=NC(CC(C4=CC=CC=C4)C5=CC=CC=C5)=NO3)N6CCCCC6

InChI

InChIKey=DISMLHKPMHZZJD-UHFFFAOYSA-N
InChI=1S/C23H27N3O.C14H10O4/c1-4-10-19(11-5-1)21(20-12-6-2-7-13-20)18-22-24-23(27-25-22)14-17-26-15-8-3-9-16-26;15-10-7-5-9(6-8-10)13(16)11-3-1-2-4-12(11)14(17)18/h1-2,4-7,10-13,21H,3,8-9,14-18H2;1-8,15H,(H,17,18)

HIDE SMILES / InChI

Description

Prenoxdiazine under the brand name Libexin is used as an antitussive agent. It was shown, that the use of this drug for pregnant women with an unproductive cough could be beneficial.

Approval Year

Unknown

Targets

Primary TargetPharmacologyConditionPotency
phagocytosis
Activator

PubMed

Patents

20050002865
20070224187
20090317473

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Oral
ACTIVE MOIETY
Structure of PRENOXDIAZINE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966